Search Results

1 - 2 of 2 items :

  • "prostate cancer" x
  • Gastroenterology x
Clear All
The association between chronic pancreatitis and the iNOS-2087A>G polymorphism

2008; 17 (3):727-31. 26. LEE KM., KANG D., PARK S.K., BERNDT S.I., REDING D., CHATTERJEE N., et al . Nitric oxide synthase gene polymorphisms and prostate cancer risk . Carcinogenesis. 2009; 30 (4):621-5. 27. JOHANNESEN J., POCIOT F., KRISTIANSEN O.P., KARLSEN A.E., NERUP J. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population. Genes Immun. 2000; 1 (6):362-6.

Open access
VEGF expression in pancreatic cancer and other malignancies: a review of the literature

Z.B., SUN Y.Q., ZHANG C.Q. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis. Tumour Biol. 2014 Jan; 35 (1):155-60. 39. WOOLLARD D.J., OPESKIN K., COSO S., WU D., BALDWIN M.E., WILLIAMS E.D. Differential expression of VEGF ligands and receptors in prostate cancer. Prostate. 2013 May; 73 (6):563-72. 40. KOPPARAPU P.K., BOORJIAN S.A., ROBINSON B.D., DOWNES M., GUDAS L.J., MONGAN N.P., PERSSON J.L. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer. Anticancer Res. 2013 Jun

Open access